Aiforia - Medical Image Analysis Software

The company probably issued a statement that H1 sales were EUR 750k. What do the sales consist of? How is the cooperation with Mayo going, are they no longer buying services since sales are so low? Why is the revenue so weak, even though the company has been developing its services for about 5 years since the IPO? Is there no demand for the services? What is the view that the company will be cash flow positive in 2027 based on? Revenue needs to grow drastically.

4 Likes